
中文名称:艾地苯醌
CAS号:58186-27-9
分子式: C19H30O5 分子量: 338.44
产品形式: free base
研发状态: Completed
研发用途: Friedreich''s Ataxia
研究机构: Santhera Pharmaceuticals
研发日期: Apr-11
研发阶段: Phase 3
Idebenone (CV-2619) is a synthetic analog of coenzyme Q10 (CoQ10) and a brain stimulant.
中文名称:乙胺嘧啶
CAS号:58-14-0
分子式: C12H13ClN4 分子量: 248.71
产品形式: free base
研发状态: Recruiting
研发用途: Head and Neck Cancer; Cancer of the Head and Neck
研究机构: Washington University School of Medicine; Tilde Sciences
研发日期: August 3 2023
研发阶段: Early Phase 1
Pyrimethamine(RP 4753) is a dihydrofolate reductase (DHFR) inhibitor, used as an antimalarial drug.
中文名称: 米替福新
CAS号:58066-85-6
分子式: C21H46NO4P 分子量: 407.57
产品形式: free base
研发状态: Not yet recruiting
研发用途: Cutaneous Leishmaniases; Treatment Adherence; Primary Health Care; Drug Evaluation
研究机构: Centre Hospitalier de Cayenne
研发日期: August 8 2022
研发阶段: --
Miltefosine (Hexadecylphosphocholine) inhibits PI3K/Akt activity with ED50 of 17.2 μM and 8.1 μM in carcinoma cell lines A431 and HeLa, first oral drug for Visceral leishmaniasis, effective against both promastigotes and amastigotes.
中文名称:克拉维酸
CAS号:58001-44-8
分子式: C8H9NO5 分子量: 199.16
产品形式: free base
研发状态: Recruiting
研发用途: Pediatric; Bacterial Infections
研究机构: Kaizen Bioscience Co.
研发日期: August 9 2023
研发阶段: Phase 1
Clavulanic acid is a naturally occurring, powerful bacterial β-lactamase inhibitor. The beta-lactam ring found in clavulanic acid binds to the active site of beta-lactamase, resulting in enzyme inactivation and enhancing the antibacterial activity of beta-lactam antibiotics like amoxicillin.
中文名称:2-(2-(4-(3-甲基苯基)-1-哌嗪基)乙基)喹啉
CAS号:57961-90-7
分子式: C22H25N3 分子量: 331.45
产品形式: free base
研发状态: Completed
研发用途: Hypovolemic Shock; Blood Loss
研究机构: Pharmazz Inc.
研发日期: May 29 2017
研发阶段: Phase 2
Centhaquin (Centhaquine, PMZ-2010), a potential agent for treatment of haemorrhagic shock, can augment cardiac output, reduce systemic vascular resistance in haemorrhagic models.
中文名称:氯氮平
CAS号:5786-21-0
分子式: C18H19ClN4 分子量: 326.82
产品形式: free base
研发状态: Recruiting
研发用途: Treatment Resistant Schizophrenia
研究机构: All India Institute of Medical Sciences Bhubaneswar
研发日期: August 31 2023
研发阶段: Phase 4
Clozapine (HF 1854, LX 100-129) is an atypical antipsychotic drug by acting as a 5-HT antagonist, used in the treatment of schizophrenia.
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
